Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Eugene Jerome Mark, M.D.

Co-Author

This page shows the publications co-authored by Eugene Mark and Mari Mino-Kenudson.
Connection Strength

2.376
  1. Reflex testing for epidermal growth factor receptor mutation and anaplastic lymphoma kinase fluorescence in situ hybridization in non-small cell lung cancer. Arch Pathol Lab Med. 2011 May; 135(5):655-64.
    View in: PubMed
    Score: 0.493
  2. Expanded acceptance of acute exacerbation of nonspecific interstitial pneumonia, including 7 additional cases with detailed clinical pathologic correlation. Pathol Int. 2018 Jul; 68(7):401-408.
    View in: PubMed
    Score: 0.200
  3. Programmed Cell Death Ligand (PD-L1) Expression in Stage II and III Lung Adenocarcinomas and Nodal Metastases. J Thorac Oncol. 2017 03; 12(3):458-466.
    View in: PubMed
    Score: 0.180
  4. Programmed Cell Death Ligand 1 Expression in Resected Lung Adenocarcinomas: Association with Immune Microenvironment. J Thorac Oncol. 2016 11; 11(11):1869-1878.
    View in: PubMed
    Score: 0.178
  5. Napsin A/p40 antibody cocktail for subtyping non-small cell lung carcinoma on cytology and small biopsy specimens. Cancer Cytopathol. 2016 Jul; 124(7):472-84.
    View in: PubMed
    Score: 0.172
  6. Tumor islands in resected early-stage lung adenocarcinomas are associated with unique clinicopathologic and molecular characteristics and worse prognosis. Am J Surg Pathol. 2013 Feb; 37(2):287-94.
    View in: PubMed
    Score: 0.139
  7. Histologic and cytomorphologic features of ALK-rearranged lung adenocarcinomas. Mod Pathol. 2012 Nov; 25(11):1462-72.
    View in: PubMed
    Score: 0.133
  8. Distinct histopathology of acute onset or abrupt exacerbation of hypersensitivity pneumonitis. Hum Pathol. 2012 May; 43(5):660-8.
    View in: PubMed
    Score: 0.126
  9. Acute fibrinous and organizing pneumonia in systemic lupus erythematosus: a case report and review of the literature. Pathol Int. 2010 Nov; 60(11):755-9.
    View in: PubMed
    Score: 0.117
  10. A novel, highly sensitive antibody allows for the routine detection of ALK-rearranged lung adenocarcinomas by standard immunohistochemistry. Clin Cancer Res. 2010 Mar 01; 16(5):1561-71.
    View in: PubMed
    Score: 0.113
  11. Reply to Wijmans et al.: Optical Coherence Tomography: A Valuable Novel Tool for Assessing the Alveolar Compartment in Interstitial Lung Disease? Am J Respir Crit Care Med. 2018 05 01; 197(9):1232-1233.
    View in: PubMed
    Score: 0.050
  12. Endobronchial Optical Coherence Tomography for Low-Risk Microscopic Assessment and Diagnosis of Idiopathic Pulmonary Fibrosis In Vivo. Am J Respir Crit Care Med. 2018 04 01; 197(7):949-952.
    View in: PubMed
    Score: 0.050
  13. Hypersensitivity Pneumonitis A Perspective From Members of the Pulmonary Pathology Society. Arch Pathol Lab Med. 2018 Jan; 142(1):120-126.
    View in: PubMed
    Score: 0.047
  14. Diagnosing lung carcinomas with optical coherence tomography. Ann Am Thorac Soc. 2015 Feb; 12(2):193-201.
    View in: PubMed
    Score: 0.040
  15. Toward the guidance of transbronchial biopsy: identifying pulmonary nodules with optical coherence tomography. Chest. 2013 Oct; 144(4):1261-1268.
    View in: PubMed
    Score: 0.036
  16. Optical frequency domain imaging of ex vivo pulmonary resection specimens: obtaining one to one image to histopathology correlation. J Vis Exp. 2013 Jan 22; (71).
    View in: PubMed
    Score: 0.035
  17. Seeing beyond the bronchoscope to increase the diagnostic yield of bronchoscopic biopsy. Am J Respir Crit Care Med. 2013 Jan 15; 187(2):125-9.
    View in: PubMed
    Score: 0.035
  18. Volumetric optical frequency domain imaging of pulmonary pathology with precise correlation to histopathology. Chest. 2013 Jan; 143(1):64-74.
    View in: PubMed
    Score: 0.035
  19. In vivo optical coherence tomography: the role of the pathologist. Arch Pathol Lab Med. 2012 Dec; 136(12):1492-501.
    View in: PubMed
    Score: 0.034
  20. ROS1 rearrangements define a unique molecular class of lung cancers. J Clin Oncol. 2012 Mar 10; 30(8):863-70.
    View in: PubMed
    Score: 0.032
  21. Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors. Sci Transl Med. 2011 Mar 23; 3(75):75ra26.
    View in: PubMed
    Score: 0.031
  22. Whole-slide imaging digital pathology as a platform for teleconsultation: a pilot study using paired subspecialist correlations. Arch Pathol Lab Med. 2009 Dec; 133(12):1949-53.
    View in: PubMed
    Score: 0.028
  23. Unique clinicopathologic features characterize ALK-rearranged lung adenocarcinoma in the western population. Clin Cancer Res. 2009 Aug 15; 15(16):5216-23.
    View in: PubMed
    Score: 0.027
  24. Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4-ALK. J Clin Oncol. 2009 Sep 10; 27(26):4247-53.
    View in: PubMed
    Score: 0.027
  25. Histopathology of coronary in-stent restenosis following gamma brachytherapy. Heart. 2003 Jan; 89(1):11-3.
    View in: PubMed
    Score: 0.017
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.